Today: 13 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime shares fell nearly 9% to $336.50 Monday afternoon, erasing earlier gains and much of their start-of-year advance. The drop came after the stock surpassed the average analyst target of $355, drawing valuation scrutiny. The move contrasted with a 1.7% gain in the PHLX Semiconductor Index as chip stocks broadly rallied. Investors are watching for SiTime’s next earnings update.
5 January 2026
····
Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

Structure Therapeutics shares fell 7.7% to $62.86 after Novo Nordisk began U.S. sales of its Wegovy pill at $149 a month for self-paying patients. Structure’s stock had reached $72.02 earlier in the session before retreating. Investors await updates on its Phase 3 plans and next earnings report, expected Feb. 26.
5 January 2026
·····
Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Astera Labs shares dropped 8.4% to $164.50 Monday after a regulatory filing showed general counsel Philip Mazzara plans to sell 30,000 shares worth about $5 million. The stock reversed from a session high near $185, trading over 5 million shares by early afternoon. Semiconductor ETFs rose, but Astera lagged. Investors are watching for further insider filings and signals from hyperscale customers.
5 January 2026
·
Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals shares fell 6.9% to $63.11 Monday after Health Canada approved Redemplo, its triglyceride-lowering drug for familial chylomicronemia syndrome. The stock dropped despite the clearance, tracking weakness across biotech stocks. Investors now await Arrowhead’s obesity data webinar on Jan. 6 and its J.P. Morgan conference presentation Jan. 12.
5 January 2026
···
Claire’s and TOFS teeter on administration as UK high street faces fresh jobs shock

Claire’s and TOFS teeter on administration as UK high street faces fresh jobs shock

Claire’s and The Original Factory Shop are preparing to file for insolvency, putting about 2,500 jobs and over 300 stores at risk, Sky News reported Monday. The chains, both owned by Modella Capital, face rising costs and weaker demand after Christmas trading. Interpath Advisory is expected to handle TOFS and Kroll to handle Claire’s. Shopper footfall before Christmas fell 13.1% from a year earlier, according to Sensormatic Solutions.
5 January 2026
Hut 8 Corp stock jumps 12% as bitcoin pushes higher — traders eye Friday jobs data

Hut 8 Corp stock jumps 12% as bitcoin pushes higher — traders eye Friday jobs data

Hut 8 shares jumped about 12% to $57.47 in midday trading Monday as bitcoin rose 2.5% to $93,587. Marathon Digital, Riot Platforms, and CleanSpark also advanced. Investors are watching U.S. payroll data due Jan. 9 and monitoring bitcoin’s next move. Hut 8 recently signed a $7 billion, 15-year lease for a Louisiana data center.
5 January 2026
······
NexGen Energy stock hits a fresh 52-week high as Canada regulator deadline nears

NexGen Energy stock hits a fresh 52-week high as Canada regulator deadline nears

NexGen Energy shares hit a 52-week high of $10.70 before easing to $10.55, up 2.9% in U.S. trading Monday. The move comes ahead of a Jan. 9 deadline for public interventions on the company’s proposed Rook I uranium project. Uranium-linked stocks and the Global X Uranium ETF also climbed. The Canadian Nuclear Safety Commission will hold a second hearing on Rook I in February.
5 January 2026
··
RIOT stock rises as bitcoin climbs; Riot’s data-center pivot and $500 million share-sale plan in focus

RIOT stock rises as bitcoin climbs; Riot’s data-center pivot and $500 million share-sale plan in focus

Riot Platforms shares rose 2.4% to $14.50 by midday Monday as bitcoin climbed to about $93,612. Trading volume exceeded 6.4 million shares. Riot named Jason Chung as CFO, effective March 1, and adjusted executive pay to remove bitcoin compensation. The company launched a new at-the-market offering for up to $500 million after ending a prior $600.5 million program.
5 January 2026
······
UEC stock jumps nearly 5% as uranium price firms near $82 and miners rally

UEC stock jumps nearly 5% as uranium price firms near $82 and miners rally

Uranium Energy Corp shares rose nearly 5% to $13.76 in midday New York trading Monday, tracking gains in uranium prices and sector peers. Spot uranium touched $82 per pound, its highest since late October. Energy Fuels climbed 7%, Denison Mines gained 5%, and Cameco was little changed. Denison said its Phoenix project is construction-ready and awaiting final regulatory approvals.
5 January 2026
··
TeraWulf stock climbs as bitcoin tops $93,000 and crypto-linked shares rebound (WULF)

TeraWulf stock climbs as bitcoin tops $93,000 and crypto-linked shares rebound (WULF)

TeraWulf shares climbed 4.9% to $13.36 midday Monday, tracking a 2.2% rise in bitcoin to near $93,415. Crypto-linked stocks advanced as investors weighed geopolitical risks and awaited Friday’s U.S. jobs report for rate clues. No new company news drove the move. TeraWulf’s last major update was a December financing deal for a Texas data center joint venture.
5 January 2026
···
Ondas (ONDS) stock rises as Jan. 16 investor day and SEC resale filing sharpen focus

Ondas (ONDS) stock rises as Jan. 16 investor day and SEC resale filing sharpen focus

Ondas Holdings shares climbed 4.2% to $11.48 Monday after the company scheduled a Jan. 16 investor day and filed to register 2.4 million shares for resale by existing holders. The filing follows a restructuring of its autonomous-systems unit and a $56.6 million non-cash charge last quarter. Ondas also announced plans to change its name and move headquarters to West Palm Beach, Florida.
5 January 2026
1 … 301 302 303 304 305 … 584

Stock Market Today

  • Toast (TOST) Seen As Undervalued After Recent Share Price Drop
    March 12, 2026, 7:03 PM EDT. Toast (TOST) shares have fallen roughly 9.5% in the past week, dragging its price down to $27.60. Despite this decline, an analysis using the Excess Returns model indicates the stock is undervalued by about 18%, with an intrinsic value estimated at $33.65 per share. The model factors in a strong average Return on Equity of 22.39%, which exceeds the company's Cost of Equity, signaling efficient use of shareholder capital. Over the last year, Toast's stock has declined 15.4%, yet it holds a 58.5% gain over three years. The P/E ratio and other valuation checks currently score low, but the discounted future earnings suggest potential upside. Investors are weighing growth prospects in restaurant technology against recent volatility, making Toast a stock to watch for value opportunities.
Go toTop